The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter “THL” or “Customer”) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is 1 year (during 2019-2020). The extend of the contract (option period) is 1 year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The customer will choose the supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract. Please note that all times given in the Invitation to tender are local time in Finland. Tender annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (link).

The purpose of STM and the Customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM's side. The roles of STM and Customer are described in more detail in section “Presentation of the Contracting Authority”. The contract will be awarded to 1 supplier based on a comparison of tenders. Estimated quantity for the contract period is 47 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The estimated duration of the contract is about 1 year. After the contract period, the customer reserves the right for the option described in section “Information about additional procurement options”. Please notice that in the Section “II.2.5) Award criteria” price means the reference price. Tenders will be compared in the manner described in section “Grounds for decision” of the invitation to tender.